Searched for
CANCER MEDICINE UPDATE
These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- US to loosen marijuana rules in major shift for $47 billion industryThe United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less dangerous. This s...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
- India Budget 2026: A proposal 'close' to Sitharaman's heart found place in this year's BudgetUnion Budget 2026: Union Finance Minister Nirmala Sitharaman highlighted customs duty exemptions for life-saving medicines in the Union Bud...
- Sun Pharma's US innovative drug sales surpass generics for first timeSun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on medicines. The c...
- Govt revises prices of 71 medicines, including those for diabetes and infections: Check new ratesThe National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 71 essential drug formulations, encompassing treatments for ...
- Pharma stocks in focus after medicine tariff changes in Union Budget 2025Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance access to critical...
- Aurobindo Pharma shares jump 2% after UK arm secures regulatory approval for cancer drugAurobindo Pharma's stock rose after its subsidiary got approval for a cancer drug. CuraTeQ Biologics received the UK's MHRA approval for Be...
- AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
- Import of vital medicines from India allowed: Pakistan's drug regulatory authorityPakistan's drugs regulatory watchdog has said that hospitals and common citizens can import vital medicines, including anti-cancer drugs an...
- Cancer vaccines are being developed using tech similar to that used for Covid shotsDecades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.
- Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
- Prices of anti-diabetics and some cancer drugs likely to be cappedIndia may mandate a cut in prices of some cancer drugs, anti-diabetics and medicines for thyroid, as the government inches closer to updati...
- Top cancer drugs may come under price controlTaking cue from the WHO’s revised list of essential medicines, popular biosimilars for cancer cure may get incorporated in India’s revised ...
- Prices of cancer, cardiac drugs may be slashedThis is a departure from the existing mechanism in which all essential medicines automatically go under price control. The Standing Nationa...
- Withdrawing customs duty may lead to hike in medicine prices: DG ShahThe Central Board of Excise and Customs (CBEC) last week issued a notification withdrawing exemption of levy of basic customs duty on as ma...
- NPPA invites comments on Tata Memorial list of cancer drugs"(this is) on revision of NLEM 2011 with respect to addition/ deletion of drugs relating to oncology from price control and affordability a...
- Natco Pharma bags licence to sell Bayer's cancer drug NexavarThe government has allowed a local drugmaker Natco Pharma to make and sell a patented cancer drug at a fraction of the price charged by Ger...
Load More
